{"DataElement":{"publicId":"5280576","version":"1","preferredName":"Person Corticosteroid Immunosuppressant Therapeutic Procedure Relationship Adverse Event Administered Duration","preferredDefinition":"The duration of administration of systemic corticosteroids or other immunosuppressant as a result of treatment related adverse event.","longName":"CORT_IMMUNO_ADM_DURATION","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"5280573","version":"1","preferredName":"Person Corticosteroid Immunosuppressant Therapeutic Procedure Relationship Adverse Event Administered","preferredDefinition":"Information related to the administration of systemic corticosteroids or other immunosuppressant as a result of treatment related adverse event.","longName":"Pers_Cort_Immu_Ther_Rela_Adve_","context":"NRG","contextVersion":"1","ObjectClass":{"publicId":"2236731","version":"1","preferredName":"Person","preferredDefinition":"A human being.","longName":"C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FC6DF7-66EB-4CAB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"UMLLOADER_MAGE","dateCreated":"2005-06-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5280571","version":"1","preferredName":"Corticosteroid Immunosuppressant Therapeutic Procedure Relationship Adverse Event Administered","preferredDefinition":"Hormones synthesized in the cortex of the adrenal gland and consist of two subclasses, glucocorticoids (carbohydrate regulation) and mineralocorticoids (electrolyte regulation).:Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of suppressor T-cell populations or by inhibiting the activation of helper cells. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of interleukins and other cytokines are emerging.:An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.:A state of connectedness between people, objects, or events; to be associated or connected with something.:Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).:The act of having given something (e.g., a medication or test).","longName":"5280571v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Corticosteroid","conceptCode":"C2322","definition":"Hormones synthesized in the cortex of the adrenal gland and consist of two subclasses, glucocorticoids (carbohydrate regulation) and mineralocorticoids (electrolyte regulation).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Immunosuppressant","conceptCode":"C574","definition":"Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of suppressor T-cell populations or by inhibiting the activation of helper cells. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of interleukins and other cytokines are emerging.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Relationship","conceptCode":"C25648","definition":"A state of connectedness between people, objects, or events; to be associated or connected with something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33C4E49B-9E25-000F-E050-BB89AD430BB9","latestVersionIndicator":"Yes","beginDate":"2016-05-26","endDate":null,"createdBy":"PATELV","dateCreated":"2016-05-26","modifiedBy":"ONEDATA","dateModified":"2016-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"3260878","version":"1","preferredName":"Concomitant Medication","preferredDefinition":"Concomitant Medication per CDISC CM Definition","longName":"CM","context":"NCIP","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA1591D7-FC76-D679-E040-BB89AD43495D","latestVersionIndicator":"Yes","beginDate":"2011-08-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-08-09","modifiedBy":"DWARZEL","dateModified":"2017-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NRG CRF:NRG Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"33C4E49B-9E36-000F-E050-BB89AD430BB9","latestVersionIndicator":"Yes","beginDate":"2016-05-26","endDate":null,"createdBy":"PATELV","dateCreated":"2016-05-26","modifiedBy":"PATELV","dateModified":"2016-06-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5280574","version":"1","preferredName":"Corticosteroid Immunosuppressant Administered Duration","preferredDefinition":"The duration of administration of systemic corticosteroids or other immunosuppressant.","longName":"COR_IMMUNO_ADM_DURATION","context":"NRG","contextVersion":"1","type":"Enumerated","dataType":"ALPHANUMERIC","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"None","valueDescription":"None","ValueMeaning":{"publicId":"4759500","version":"1","preferredName":"None","longName":"4759500","preferredDefinition":"No edema","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Edema Rating 0","conceptCode":"C121310","definition":"No edema.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1226E673-50C9-B0C7-E050-BB89AD431A66","latestVersionIndicator":"Yes","beginDate":"2015-03-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"33C4E49B-9E5C-000F-E050-BB89AD430BB9","beginDate":"2016-05-26","endDate":null,"createdBy":"PATELV","dateCreated":"2016-05-26","modifiedBy":"ONEDATA","dateModified":"2016-05-26","deletedIndicator":"No"},{"value":"Less than or equal to 2 weeks","valueDescription":"Less Than or Equal To Two Week","ValueMeaning":{"publicId":"5280575","version":"1","preferredName":"Less Than or Equal To Two Week","longName":"5280575","preferredDefinition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest is smaller than the other object in one of these ways.: A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.: Any period of seven consecutive days.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Less Than or Equal To","conceptCode":"C61586","definition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest is smaller than the other object in one of these ways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Two","conceptCode":"C66833","definition":"A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Week","conceptCode":"C29844","definition":"Any period of seven consecutive days.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33C4E49B-9E6A-000F-E050-BB89AD430BB9","latestVersionIndicator":"Yes","beginDate":"2016-05-26","endDate":null,"createdBy":"PATELV","dateCreated":"2016-05-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"33C4E49B-9E83-000F-E050-BB89AD430BB9","beginDate":"2016-05-26","endDate":null,"createdBy":"PATELV","dateCreated":"2016-05-26","modifiedBy":"ONEDATA","dateModified":"2016-05-26","deletedIndicator":"No"},{"value":"Greater than 2 weeks","valueDescription":"Greater Than Two Week","ValueMeaning":{"publicId":"5280492","version":"1","preferredName":"Greater Than Two Week","longName":"5280492","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.: Any period of seven consecutive days.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Two","conceptCode":"C66833","definition":"A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Week","conceptCode":"C29844","definition":"Any period of seven consecutive days.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33C29CC6-8EED-EADA-E050-BB89AD43638A","latestVersionIndicator":"Yes","beginDate":"2016-05-26","endDate":null,"createdBy":"PATELV","dateCreated":"2016-05-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"33C4E49B-9E8D-000F-E050-BB89AD430BB9","beginDate":"2016-05-26","endDate":null,"createdBy":"PATELV","dateCreated":"2016-05-26","modifiedBy":"ONEDATA","dateModified":"2016-05-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3260878","version":"1","preferredName":"Concomitant Medication","preferredDefinition":"Concomitant Medication per CDISC CM Definition","longName":"CM","context":"NCIP","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA1591D7-FC76-D679-E040-BB89AD43495D","latestVersionIndicator":"Yes","beginDate":"2011-08-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-08-09","modifiedBy":"DWARZEL","dateModified":"2017-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2404653","version":"1","preferredName":"Duration","preferredDefinition":"The period of time during which something continues.","longName":"C25330","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Duration","conceptCode":"C25330","definition":"The period of time during which something continues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"005AD6E5-0599-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NRG CRF:NRG Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"33C4E49B-9E48-000F-E050-BB89AD430BB9","latestVersionIndicator":"Yes","beginDate":"2016-05-26","endDate":null,"createdBy":"PATELV","dateCreated":"2016-05-26","modifiedBy":"PATELV","dateModified":"2016-06-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Required the use of systemic","type":"Preferred Question Text","description":"Required the use of systemic corticosteroids or other immunosuppressant","url":null,"context":"NRG"}],"origin":"NRG CRF:NRG Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"33C51006-EDE9-B444-E050-BB89AD4366D6","latestVersionIndicator":"Yes","beginDate":"2016-05-26","endDate":null,"createdBy":"PATELV","dateCreated":"2016-05-26","modifiedBy":"PATELV","dateModified":"2016-06-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}